Favorable outcome and engraftment following reduced-intensity conditioned allo-HSCT in children with primary haemophagocytic lymphohistiocytosis (HLH) and high-risk langerhans cell histiocytosis (LCH)

被引：0
|
作者：
Moser, Laura M. [1 ]
Salzmann-Manrique, Emilia [1 ]
Jarisch, Andrea [1 ]
Soerensen, Jan [1 ]
Bakhtiar, Shahrzad [1 ]
Bader, Peter [1 ]
机构：
[1] Univ Hosp Frankfurt, Frankfurt, Germany
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P729
引用
收藏
页码：604 / 604
页数：1
相关论文
共 8 条
  • [1] Excellent outcome and engraftment after reduced-intensity conditioning regimen in children with high-risk HLH and LCH
    Bakhtiar, S.
    Moskovits, J.
    Ponstingl, E.
    Jarisch, A.
    Soerensen, J.
    Klingebiel, T.
    Bader, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S266 - S266
  • [2] Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning
    M Steiner
    S Matthes-Martin
    A Attarbaschi
    M Minkov
    N Grois
    E Unger
    W Holter
    J Vormoor
    A Wawer
    M Ouachee
    W Woessmann
    H Gadner
    Bone Marrow Transplantation, 2005, 36 : 215 - 225
  • [3] Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning
    Steiner, M
    Matthes-Martin, S
    Attarbaschi, A
    Minkov, M
    Grois, N
    Unger, E
    Holter, W
    Vormoor, J
    Wawer, A
    Ouachee, M
    Woessmann, W
    Gadner, H
    BONE MARROW TRANSPLANTATION, 2005, 36 (03) : 215 - 225
  • [4] Outcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome?
    Sedky, Mohamed S.
    Hamouda, Asmaa
    Taha, Hala
    Zaky, Iman
    Hassanain, Omayma
    El Hemaly, Ahmed
    ElHaddad, Alaa
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (08) : 635 - 643
  • [5] OUTCOME OF HIGH-RISK AND REFRACTORY AML/MDS PATIENTS RECEIVING A FLAMSA SEQUENTIAL CHEMOTHERAPY REGIMEN FOLLOWED BY REDUCED-INTENSITY CONDITIONING (RIC) AND ALLOGENEIC HEMATOPOEITIC STEM CELL TRANSPLANTATION (allo-HSCT)
    Detrait, M.
    Chevallier, P.
    Sobh, M.
    Guillaume, T.
    Thomas, X.
    Morisset, S.
    Tedone, N.
    Delaunay, J.
    Nicolini, F.
    Ducastelle, S.
    Chelghoum, Y.
    Barraco, F.
    Labussiere, H.
    Mohty, M.
    Michallet, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S335 - S336
  • [6] Outcome of High-Risk and Refractory AML/MDS Patients Receiving a FLAMSA Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)
    Detrait, Marie Y.
    Chevallier, Patrice
    Sobh, Mohamad
    Guillaume, Thierry
    Thomas, Xavier
    Morisset, Stephane
    Tedone, Nathalie
    Delaunay, Jacques
    Nicolini, Franck E.
    Labussiere, Helene
    Ducastelle, Sophie
    Fattoum, Jihane
    Barraco, Fiorenza
    Cannas, Giovanna
    Chelghoum, Youcef
    Mohty, Mohamad
    Michallet, Mauricette
    BLOOD, 2011, 118 (21) : 853 - 854
  • [7] FAVORABLE OUTCOMES IN ELDERLY AND HIGH-RISK PATIENTS WITH AML AND MDS FOLLOWING T-CELL DEPLETED REDUCED INTENSITY CONDITIONED ALLOGENEIC STEM CELL TRANSPLANTATION
    Nicholson, E.
    Mackinnon, S.
    Thomson, K. J.
    Sudak, J.
    Fielding, A. K.
    Kottaridis, P.
    Peggs, K. S.
    Morris, E. C.
    Chakraverty, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S346 - S347
  • [8] Favorable outcomes in elderly and high-risk patients with AML and MDS following T-cell depleted reduced intensity conditioned allogeneic stem cell transplantation
    Nicholson, E.
    Mackinnon, S.
    Thomson, K. J.
    Sudak, J.
    Fielding, A. K.
    Kottaridis, P.
    Peggs, K. S.
    Morris, E. C.
    Chakraverty, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 3 - 3
1